Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06776796 · ClinicalTrials.gov registry record · NA
Testing the Efficacy of a Brief Alcohol Intervention Among College Students
A NA study, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 461
- Enrollment target
NCT06776796: Completed NA study, sponsored by Georgia State University.
NCT06776796 is a NA study that has completed, run by Georgia State University. The registered enrollment target is 461 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06776796, a NA study, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 461 participants
- Enrollment target
Study Summary
Individuals will be recruited to participate in a randomized controlled trial to test the efficacy of a prevention program aimed at reducing alcohol use among college students. If randomized to the intervention, participants will view personalized content based on their alcohol use and chosen identity and learn about various topics related to alcohol use, including ways to reduce their use. Control participants will be directed to a website where information regarding mental health and substance use may be found. Baseline mental health, alcohol use, and related constructs will be assessed. Participants will complete a 3-month follow-up survey to assess the efficacy of the tool in symptom reduction.
Primary Outcome
Number of drinks will be assessed using the daily drinking questionnaire. Higher scores indicate higher alcohol use.
Interventions
- BEHAVIORAL Online Personalized Normative Feedback Intervention Targeting Alcohol Misuse
- BEHAVIORAL Mental Health and Substance Use Resources
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 461 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2024-01-21 |
| Phase | NA |
What the finished NCT06776796 record still lists
NCT06776796 is an interventional study that assigns participants to a tested intervention. The registered 461 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Online Personalized Normative Feedback Intervention Targeting Alcohol Misuse is the first listed.
NCT06776796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06776796 about?
NCT06776796 is a clinical study titled "Testing the Efficacy of a Brief Alcohol Intervention Among College Students". Individuals will be recruited to participate in a randomized controlled trial to test the efficacy of a prevention program aimed at reducing alcohol use among college students. If randomized to the intervention, participants will view personalized content based on their alcohol use and chosen identi...
What is the current status of trial NCT06776796?
This trial is currently completed. It is a NA study. The enrollment target is 461 participants. The study started on 2023-08-23. Estimated completion is 2024-01-21.
What interventions are being tested in trial NCT06776796?
The interventions under investigation include: Online Personalized Normative Feedback Intervention Targeting Alcohol Misuse (BEHAVIORAL), Mental Health and Substance Use Resources (BEHAVIORAL).
Who is sponsoring clinical trial NCT06776796?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06776796's enrollment target sits among peer trials
461 222nd of 2000 higher than 1,779 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04546399 · 461 participants · Phase 2
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT00949819 · 462 participants
Active Surveillance for Cancer of the Prostate (ASCaP)
- NCT05126277 · 462 participants · Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI